LIVECAST Markets Briefs Calendar Search

Research

Macro Politics Crypto Prediction Markets Disclosure Wire News Archive

LIVECAST Markets

Menu

Home LIVECAST Markets Briefs Calendar Search Macro Politics Crypto Prediction Markets Disclosure Wire News Archive

Live News EQUITY L impact Jul 28, 2026, 10:57 AM UTC

Coca-Cola reports Q2 comparable EPS 97c, consensus 93c

Reports Q2 revenue...

SquawkNews Newsroom

Reports Q2 revenue...

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

KO

Related stories

DARE - Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopa DARE - Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx - Click For Release L impact | EQUITY | Jul 28, 2026, 12:34 PM UTC MNTS - Momentus’ Vigoride 8 Spacecraft Successfully Completes Critical Design Review Milestone for 2027 Mission Launch - Click For Release MNTS - Momentus’ Vigoride 8 Spacecraft Successfully Completes Critical Design Review Milestone for 2027 Mission Launch - Click For Release L impact | EQUITY | Jul 28, 2026, 12:33 PM UTC ANGO - AngioDynamics to Participate in Upcoming Investor Conferences - Click For Release ANGO - AngioDynamics to Participate in Upcoming Investor Conferences - Click For Release L impact | EQUITY | Jul 28, 2026, 12:33 PM UTC IR - Ingersoll Rand to Participate in Upcoming Investor Conference - Click For Release IR - Ingersoll Rand to Participate in Upcoming Investor Conference - Click For Release L impact | EQUITY | Jul 28, 2026, 12:33 PM UTC NAGE - Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside NAGE - Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle- L impact | EQUITY | Jul 28, 2026, 12:33 PM UTC SEGG segg Media: believes increased damages are warranted because its stock price has continued to decline since original petition was filed SEGG segg Media: believes increased damages are warranted because its stock price has continued to decline since original petition was filed L impact | EQUITY | Jul 28, 2026, 12:33 PM UTC

SQUAWK/NEWS

Real-time financial news agency for traders. Market-relevant headlines on screen and read aloud through the LiveCast audio squawk.

Pro plan coming — join the list.

Product

LiveCast
Live Markets
Session Briefs
Calendar
Search

Research

Macro
Politics
Crypto
Prediction Markets
Disclosure Wire
News Archive

For Traders

Market Movers
US Stocks
News for Traders
How to Trade News
What Is a Squawk
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews robots / sitemap Privacy Policy SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.

We use analytics (GA4, Clarity, PostHog) to improve the product. Privacy Policy